Cannara Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Feb 24 | BuyUS$72,129 | Investissements Olymbec Inc. | Company | 100,000 | US$0.74 | |
16 Aug 23 | BuyUS$1,519 | Donald Olds | Individual | 1,900 | US$0.80 | |
31 May 23 | BuyUS$54,747 | Investissements Olymbec Inc. | Company | 66,000 | US$0.83 | |
31 May 23 | BuyUS$43,964 | Derek Stern | Individual | 53,000 | US$0.83 | |
30 May 23 | BuyUS$65,749 | Investissements Olymbec Inc. | Company | 91,000 | US$0.74 | |
30 May 23 | BuyUS$2,162 | Scott Carroll | Individual | 3,050 | US$0.82 | |
26 May 23 | BuyUS$312 | Investissements Olymbec Inc. | Company | 500 | US$0.62 | |
25 May 23 | BuyUS$9,044 | Investissements Olymbec Inc. | Company | 14,500 | US$0.63 | |
19 May 23 | BuyUS$7,701 | Investissements Olymbec Inc. | Company | 12,025 | US$0.65 | |
12 May 23 | BuyUS$2,785 | Derek Stern | Individual | 4,500 | US$0.62 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 809,347 | 0.899% |
Private Companies | 43,873,739 | 48.7% |
General Public | 45,335,866 | 50.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
24,258,982 | US$13.8m | 0% | no data | |||
19,614,757 | US$11.1m | 0.51% | no data | |||
376,040 | US$213.2k | 0% | no data | |||
219,000 | US$124.2k | 0% | no data | |||
126,272 | US$71.6k | 1.37% | no data | |||
47,250 | US$26.8k | 0% | no data | |||
20,980 | US$11.9k | 0% | no data | |||
16,700 | US$9.5k | 0% | no data | |||
3,105 | US$1.8k | 0% | no data |